The choice of EGF as the acute signaling stimulus over TGF-β was made, first, to avoid potentially confounding input signals due to the chronic TGF-β treatment used induce EMT, and second, due to the relevance of proliferative EGF signaling and potential in the tumor context. The gene discussed is TGFB1; the disease is neoplasm.